The watchdog group Empower Oversight has released new documents related to the ongoing controversy over US taxpayer-funded research for ‘gain of function’ studies at the Wuhan, China lab that many experts believe was the source of Covid-19. According to Empower […]
The following is an excerpt from Nature. The US National Institutes of Health (NIH) has reinstated a grant to a highly scrutinized research organization that studies bat coronaviruses — but the agency has placed several stipulations on the scope of the research
NIH has reinstated the Eco-Health Alliance grant to resume controversial bat research Read More »
The watchdog group Empower Oversight has filed Freedom of Information Act requests for information after learning of the failure by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Disease (NIAID) to hold a key
(READ) Watchdog questions lack of govt. oversight on coronavirus research grants Read More »
Dr. Anthony Fauci, who oversees the National Institute for Allergy and Infectious Diseases (NIAID), is being asked to explain a new grant of tax money awarded to EcoHealth Alliance to study bat coronaviruses in Asia. EcoHealth Alliance is a controversial
The watchdog group Judicial Watch has announced that it received 1651 pages of records from the National Institutes of Health (NIH), revealing an FBI inquiry into the NIH’s controversial bat coronavirus grant tied to China’s Wuhan Institute of Virology. The records also
The lead Republican on the House Oversight Committee, James Comer (R-Kentucky) and other Republican lawmakers have renewed a request to Department of Health and Human Services (HHS) Secretary Xavier Becerra and National Institutes of Health (NIH) Acting Director Lawrence Tabak
(READ) Republicans pressure HHS to release docs U.S. grant money funneled to China Lab Read More »
A fact-based investigation by Sharyl Attkisson into what we know, and can prove, about the origins of Covid-19.
Sharyl Attkisson Investigates Covid-19 Origins (PODCAST) Read More »
